This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Nancy J Levy: Innovator in Bacterial Vaccines
Introduction
Nancy J Levy is a prominent inventor based in Newton Center, MA (US). She has made significant contributions to the field of immunology, particularly in the development of bacterial antigens and vaccines. Her work has the potential to impact public health by providing new methods for combating bacterial infections.
Latest Patents
Nancy J Levy holds a patent for "Bacterial antigens, antibodies, vaccines and methods of manufacture." This patent focuses on antigens and vaccines containing purified oligomers of the repeating pentasaccharide unit of type III Group B Streptococcus polysaccharide capsule. The methods described in her patent involve recovering polysaccharide from cultured III GBS or medium and digesting it with a specific endo-.beta.-galactosidase. The enzymatic cleavage of bacterial polysaccharide allows for the creation of purified oligomers. Additionally, her patent includes a purified trypsin-resistant C surface protein, with a molecular weight of about 14,000, and outlines methods for passive immunization using the developed vaccines.
Career Highlights
Nancy J Levy is affiliated with The Brigham and Women's Hospital, Inc., where she continues her research and development efforts. Her work has garnered attention for its innovative approach to vaccine development and its potential applications in clinical settings.
Collaborations
Throughout her career, Nancy has collaborated with notable colleagues, including Dennis L Kasper and Harold J Jennings. These collaborations have further enriched her research and contributed to advancements in the field of immunology.
Conclusion
Nancy J Levy is a trailblazer in the development of bacterial vaccines, with a focus on innovative methods for creating effective immunological responses. Her contributions to the field are invaluable and continue to pave the way for future advancements in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
